Released June 17, 2019 | SUGAR LAND
en
There are 471 Pharma-Bio Industry projects across the globe scheduled to launch construction by the time June comes to a close. Representing $10.5 billion in potential investment, Industrial Info covers both capital and scheduled maintenance projects. Click here for a list of projects.
North American activity accounts for $5 billion, or 50% of the total, with Europe anticipating $3 billion. Pharmaceutical manufacturing accounts for $2.8 billion divided among 196 projects, while biological manufacturing has $1.8 billion across 78 projects.
North American activity accounts for $5 billion, or 50% of the total, with Europe anticipating $3 billion. Pharmaceutical manufacturing accounts for $2.8 billion divided among 196 projects, while biological manufacturing has $1.8 billion across 78 projects.
